A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Abemaciclib|DRUG: Anastrozole|DRUG: Letrozole|DRUG: Placebo|DRUG: Fulvestrant
Sponsor: Eli Lilly and Company